Recombinant Human Anti-CA9 x Human Anti-CD55 Bispecific Antibody (Single-chain Triplebody) (SCTB-H186)

Recombinant Anti-CA9 x Anti-CD55 Bispecific Antibody (Single-chain Triplebody) is designed to be expressed as a single chain with three scFv units, two distal binding sites for CA9 and a central site for CD55. It contains a His-tag at the C/N terminus for affinity purification. This BsAb can recruit complements to tumor cells. It is designed for the research of Renal cell cancer (RCC); Solid tumors therapy.

Datasheet INQUIRY

Specifications

Targets

CD55 & CA9

Type

Single-chain Triplebody

Species Reactivity

Human

Application

FuncS; Promising therapeutic agent

Related Disease

Renal cell cancer (RCC); Solid tumors

Targets

Target 1

CD55

Gene ID

1604

UniProt ID

P08174

Alternative Names

CD55; CD55 molecule, decay accelerating factor for complement (Cromer blood group); CR; TC; DAF; CROM; complement decay-accelerating factor; CD55 antigen

Target 2

CA9

Gene ID

768

UniProt ID

Q16790

Alternative Names

CA9; carbonic anhydrase 9; RCC-associated antigen G250; G250; CA-IX; carbonic anhydrase IX; MN; CAH9

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Human Anti-CA9 x Human Anti-CD55 Bispecific Antibody (Single-chain Triplebody) (SCTB-H186). Click the button below to contact us or submit your feedback about this product.

Recombinant Human Anti-CA9 x Human Anti-CD55 Bispecific Antibody (Single-chain Triplebody) (CAT#: SCTB-H186)

Specifications

Targets

Customer Reviews and Q&As